Morpholine → HCID 131730332, compound
Reaction equation
[Cl:1][C:2]1[C:6]([Cl:7])=[C:5]([CH3:8])[NH:4][C:3]=1[C:9]([NH:11][CH:12]1[CH2:17][CH2:16][N:15]([C:18]2[S:19][C:20]([C:25]([O:27][CH2:28][CH3:29])=[O:26])=[C:21]([CH:23]=O)[N:22]=2)[CH2:14][CH:13]1[O:30][CH3:31])=[O:10].C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+].[NH:46]1[CH2:51][CH2:50][O:49][CH2:48][CH2:47]1>C(Cl)Cl.Cl>[Cl:1][C:2]1[C:6]([Cl:7])=[C:5]([CH3:8])[NH:4][C:3]=1[C:9]([NH:11][C@H:12]1[CH2:17][CH2:16][N:15]([C:18]2[S:19][C:20]([C:25]([O:27][CH2:28][CH3:29])=[O:26])=[C:21]([CH2:23][N:46]3[CH2:51][CH2:50][O:49][CH2:48][CH2:47]3)[N:22]=2)[CH2:14][C@H:13]1[O:30][CH3:31])=[O:10]Participants
Procedure
To a solution of ethyl 2-(4-{[(3,4-dichloro-5-methyl-1H-pyrrol-2-yl)carbonyl]amino}-3-methoxypiperidin-1-yl)-4-formyl-1,3-thiazole-5-carboxylate (0.15 g, 0.31 mmol, Example 252) in methylene chloride (20 mL) was added sodium triacetoxyborohydride (0.1 g, 0.47 mmol) and morpholine (0.03 mL, 0.34 mmol). Reaction was stirred at room temperature and monitored by LCMS. Upon completion, the reaction mixture was diluted with 1N HCl and then partitioned with EtOAc/sat. sodium bicarbonate. Washing with brine, drying with MgSO4 and concentrating yielded a solid. Purification by silica gel flash column (gradient elution 70-100% EtOAc/CH2Cl2) afforded pure product (0.091 g) MS (ES) M+H+: 560 for C23H31Cl2N5O5S; NMR: 1.24 (t, 3 H) 1.75 (s, 2 H) 2.18 (s, 3 H) 3.32 (s, 2 H) 3.36 (s, 3 H) 3.52 (s, 2 H) 3.54 (d, 4 H) 3.65-3.75 (m, 2 H) 3.76-3.86 (m, 2 H) 3.93 (s, 1 H) 4.18 (q, 2 H) 4.27 (s, 1 H) 7.16 (d, 1 H) 12.16 (s, 1 H).
Workup
- customReaction
- custompartitioned with EtOAc/
- washWashing with brine
- dry with materialdrying with MgSO4
- concentrationconcentrating
- customyielded a solid
- customPurification
- washby silica gel flash column (gradient elution 70-100% EtOAc/CH2Cl2)
Sources & evidence
- ORD record
- ord-5018e5a7072e4714abbc4d3f4db220c7
- Source dataset
- uspto-grants-2013_03
- Patent number
- US08399489B2
Reaction notes
Loading…